Broadcrest Asset Management’s Bio-Techne TECH Stock Holding History

Broadcrest Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$5.56M	Sell	100,000 -25,000	-20%	-$1.34M	12.62%	4
2025 Q2	$6.43M	Sell	125,000 -25,000	-17%	-$1.26M	11.74%	5
2025 Q1	$8.79M	Buy	150,000 +50,000	+50%	+$3.39M	16.73%	3
2024 Q4	$7.2M	Sell	100,000 -100,000	-50%	-$7.34M	10.79%	3
2024 Q3	$16M	Buy	200,000 +100,000	+100%	+$7.51M	19.21%	3
2024 Q2	$7.62M	Buy	100,000 +20,000	+25%	+$1.47M	9.37%	4
2024 Q1	$5.63M	Sell	80,000 -220,000	-73%	-$15.7M	7.56%	5
2023 Q4	$23.1M	Buy	300,000 +25,000	+9%	+$1.65M	20.92%	2
2023 Q3	$18.7M	Sell	275,000 -25,000	-8%	-$1.97M	20.14%	2
2023 Q2	$24.5M	Buy	300,000 +50,000	+20%	+$4.02M	21.05%	2
2023 Q1	$18.5M	Buy	250,000 +150,000	+150%	+$11.6M	16.12%	3
2022 Q4	$8.29M	Buy	+100,000	New	+$7.94M	9.05%	5

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Broadcrest Asset Management's TECH Position: Q3 2025 in Review

Broadcrest Asset Management reduced its Bio-Techne (TECH) stake by 20% in Q3 2025, selling an estimated $1.34M and leaving 100,000 shares worth $5.56M. The position accounts for 12.62% of the portfolio, ranked #4.

Broadcrest Asset Management first reported a position in TECH in Q4 2022 and has held it in 12 quarters since. The position peaked at $24.5M in Q2 2023. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

Broadcrest Asset Management held 100,000 shares of Bio-Techne worth $5.56M as of Q3 2025.
Broadcrest Asset Management sold 25,000 Bio-Techne shares in Q3 2025, an estimated $1.34M.
Bio-Techne made up 12.62% of Broadcrest Asset Management's portfolio in Q3 2025, its #4 holding.
Broadcrest Asset Management first reported a position in Bio-Techne in Q4 2022 and has held it in 12 quarters since.
Broadcrest Asset Management's Bio-Techne position peaked at $24.5M in Q2 2023.
577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Broadcrest Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.